Photo via Fox News

Common blood pressure drug helps more stroke survivors reach critical health target

Read the original at Fox News ↗
Cite

McGreal, K. (2026, November 15). Common blood pressure drug helps more stroke survivors reach critical health target. Fox News. https://www.foxnews.com/health/common-blood-pressure-drug-helps-stroke-survivors-reach-critical-health-target

Dated from the outlet's own feed. Check the original for its byline.

Fox News · collected 2026-11-15 · by Kelly McGreal

Quick Summary

A study presented at the American Heart Association's Scientific Sessions suggests that adding spironolactone, a low-cost medication, to post-stroke treatment helps lower blood pressure more effectively than usual care alone. The REDUCE trial, which involved 160 participants, showed that those taking spironolactone had an average systolic blood pressure 8 points lower than those receiving standard care after three months. Additionally, 52% of participants on spironolactone reached the recommended blood pressure target of less than 130/80, compared to 30% in the control group. Dr. Jordana Cohen, a study co-author, emphasized the potential for spironolactone to reduce the risk of future strokes and heart attacks, though Dr. Alfred Joshua noted that more research is needed to confirm these benefits.
Written by AI on 2026-11-16, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

A new study presented at the American Heart Association's Scientific Sessions in Chicago from November 6-9, 2026, suggests that spironolactone, a low-cost medication commonly known as a water pill, can help stroke survivors whose blood pressure remains elevated despite treatment. The study, called the REDUCE trial, involved 160 participants and was set to include 200 but ended early. The trial compared participants who added spironolactone to their regular treatment with those who continued usual post-stroke care. After three months, the top blood pressure number for those taking spironolactone was nearly 8 points lower on average compared to those receiving usual care, with an average of 126 versus 133. Additionally, 52% of patients on spironolactone reached the recommended blood pressure goal of less than 130/80, compared to only 30% of those receiving usual care. This research highlights the potential of spironolactone in improving outcomes for stroke survivors.

Written for “Blood Pressure Drug Helps Stroke Survivors” on 2026-11-17, grounded in this article and the 0 other(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.

Story

Blood Pressure Drug Helps Stroke Survivors
Health · 1 article(s) covering the same event.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
23
sentences that state something as happening or true
Uncertain
22%
5 of 23 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
67/100
Fox News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-16 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Fox News · 7957 article(s) · 14 correction(s) detected
Running correction rate · 14 correction(s)

Who wrote this

Kelly McGreal
59 article(s) here · 1 carrying a prediction
"I kept watching, hoping that it would veer away.
A low-cost medication could help stroke survivors whose blood pressure remains elevated despite treatment, a new study suggests.
Cutting ahead of others to grab just one item may seem a harmless action, but it can frustrate fellow passengers who have been patiently waiting their turn.
"The FAA will certainly want to take a closer look at this."
Flood said his concern about how military history is taught partly comes from his own experience in school, though he says that may or may not be typical.
"If there's a market for it, people will attempt to smuggle it," Jeffries said.
With France's four largest railway unions joining the multi-sector walkout, unapproved protests are expected to spill outside planned routes through the weekend.
CAAN has opened an investigation into the accident and will determine whether corrective action is needed based on its findings.
The speed a person normally walks could offer a simple clue about their overall health and longevity, new research suggests.
Postmenopausal women who use testosterone therapy could face a higher risk of heart attack, stroke and other cardiovascular problems, new research suggests.
Also by Kelly McGreal
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 59 articles by Kelly McGreal →

Topics

Chicago REDUCE Scientific Sessions the American Heart Association's the University of Pennsylvania

Subjects

Joshua PERSON · 3× Fox News Digital ORG · 2× Alfred Joshua PERSON · 1× California GPE · 1× Chicago GPE · 1× Jordana Cohen PERSON · 1× REDUCE ORG · 1× the American Heart Association's ORG · 1× the U.S. National Library of Medicine ORG · 1× the University of Pennsylvania ORG · 1×

Narrative

The trial ended early with 160 participants instead of the planned 200, and about 15% did not have blood pressure readings available at the three-month mark, the researchers noted. People taking spironolactone were also taking slightly more blood pressure medications overall than those receiving usual care. The study was not designed to determine whether spironolactone actually prevents another stroke or heart attack.
framing: mixed · carried by 1 article(s) · first seen 2026-11-16
A low-cost medication could help stroke survivors whose blood pressure remains elevated despite treatment, a new study suggests.

Claims (23 extracted, 5 hedged)

A low-cost medication could help stroke survivors whose blood pressure remains elevated despite treatment, a new study suggests. uncertain
study → help → treatment
The research, known as the REDUCE trial, looked at whether adding spironolactone, a medication commonly known as a water pill, could help lower blood pressure after a stroke. uncertain
adding → know → stroke
The findings were presented at the American Heart Association's Scientific Sessions, Nov. 6-9, 2026, in Chicago. asserted
findings → present → Chicago
Participants were split into two groups. asserted
Participants → split → groups
One added spironolactone to their regular treatment, while the other continued with usual post-stroke care. asserted
other → add → care
Researchers tracked the participants' blood pressure at home over the following six months to determine whether adding the medication made a difference. asserted
adding → track → difference
After three months, the top blood pressure number was nearly eight points lower on average among people taking spironolactone compared with those receiving usual care – about 126 versus 133, the study said. asserted
study → take → 133
More patients taking spironolactone also reached the recommended blood pressure goal of less than 130/80. asserted
patients → take → 130/80
That included 52% of those taking the medication compared with 30% receiving usual care. asserted
That → include → care
"Lowering blood pressure is the most important step in preventing another stroke, yet many survivors struggle to reach recommended blood pressure targets after a stroke," study co-lead author Dr. Jordana Cohen, an associate professor of medicine and epidemiology at the University of Pennsylvania, said in a news release. asserted
Cohen → lower → release
"When spironolactone was added to post-stroke care, we saw a meaningful drop in blood pressure that may lower the risk of future strokes and heart attacks," she added. uncertain
she → add → strokes
Dr. Alfred Joshua, a California-based board-certified emergency physician and former chief medical officer who was not involved in the research, said the findings are encouraging, but do not yet show that the medication prevents a subsequent stroke. asserted
medication → base → stroke
"We already know that controlling blood pressure lowers the risk of another stroke," Joshua told Fox News Digital. asserted
Joshua → know → Digital
"This study measured blood pressure, so whether adding spironolactone leads to fewer repeat strokes is still an open question. asserted
leads → measure → strokes
Spironolactone works by helping the body get rid of extra salt and water, which can lower blood pressure, according to the U.S. National Library of Medicine. uncertain
which → work → Medicine
It also causes the body to hold onto potassium, so patients taking it need to have their levels checked, the drug’s prescribing information states. asserted
information → cause → it
Joshua warned that high potassium is one of the main safety concerns because it can develop without symptoms. asserted
it → warn → symptoms
The risk can be higher for people with kidney problems and those taking certain medications or potassium supplements. asserted
risk → take → medications
The medication can also lower blood pressure enough to cause dizziness, he added. asserted
he → lower → dizziness
"If your blood pressure is still high after a stroke, bring your home readings to your clinician and ask whether this medication is a good fit," Joshua advised. asserted
Joshua → bring → clinician
The trial ended early with 160 participants instead of the planned 200, and about 15% did not have blood pressure readings available at the three-month mark, the researchers noted. People taking spironolactone were also taking slightly more blood pressure medications overall than those receiving usual care. The study was not designed to determine whether spironolactone actually prevents another stroke or heart attack. asserted
spironolactone → end → stroke
Larger and longer studies are needed to answer that question, according to the researchers. uncertain
studies → need → researchers
Fox News Digital reached out to the researchers for comment. asserted
Digital → reach → comment
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support